University Hospital Cologne

Cologne, Germany


Chemotherapy with Cisplatin of teratoma (1 course) (program ID: 208453)


Michael Hallek

Prof. Dr. med.

Michael Hallek

Department of Internal Medicine I: oncology, hematology, clinical infectology, clinical immunology, hemostasis, intensive care

Specialized in: oncology, hematology, clinical infectology, clinical immunology, hemostasis, intensive care

Curriculum vitae keyboard_arrow_down

Studium

  • 1978-1985 Medizinstudium in Regensburg, München und Paris

Beruflicher Werdegang

  • 1985-1990 Assistenzarzt, Pharmakologie und Innere Medizin, TU und Universität München (Prof. Szinicz, Prof. Blömer, Prof. Buchborn)
  • 1990-1992 Research Associate, Dana Farber Cancer Institute, Harvard Medical School, Boston, USA (Prof. Dr. J. Griffin)
  • 1992-1995 Assistenzarzt, Medizinische Klinik, Klinikum Innenstadt, Universität München (Direktor: Prof. Dr.Dr. h.c. P.C. Scriba)
  • 1994-heute Leiter der Arbeitsgruppe für Gentherapie, Genzentrum der Universität München (Direktor: Prof. Dr. E.-L. Winnacker)
  • 1995-1998 Oberarzt, Abteilung für Hämatologie und Onkologie, Medizinische Klinik, Klinikum Innenstadt, Universität München (Direktor: Prof. Dr.Dr.h.c. P.C. Scriba)
  • 1998-2003 Oberarzt, Medizinische Klinik III, Klinikum Großhadern, Universität München (Direktor: Prof. Dr. W. Hiddemann) Oberarzt der hämatologischonkologischen Poliklinik, Aufbau und Neustrukturierung (1998-1999).
  • August 1999 Ruf auf eine C3-Professur für Innere Medizin der Universität München.
  • März 2003 Ruf auf eine C4-Professur für Innere Medizin der Universität zu Köln (Nachfolge Prof. Diehl).
  • Seit November 2003 Direktor der Klinik für Innere Medizin I (Hämatologie, Onkologie, Infektiologie, klinische Immunologie und internistische Intensivmedizin) der Universität zu Köln.

Tätigkeiten in der akademischen Selbstverwaltung (Auswahl)

  • 1996-heute Gründer und Leiter der Deutschen CLL-Studiengruppe
  • 2002-heute Vorsitzender der Deutschen Gesellschaft für Gentherapie
  • 2004-heute Mitglied des wissenschaftlichen Beirats der Deutschen Krebshilfe/Dr. Mildred-Scheel-Stiftung (Bereich experimentelle Forschung).

Auszeichnungen, Stipendien (Auswahl)

  • 1978-1985 Stipendium nach dem Bayerischen Begabtenförderungsgesetz
  • 1980-1985 Stipendium des Cusanuswerks
  • 1982-1983 Auslandstipendien des Deutschen Akademischen Austauschdienstes und der Französischen Regierung
  • 1990-1992 Ausbildungsstipendium der Deutschen Forschungsgemeinschaft
  • 1999 Artur-Pappenheim-Preis der Deutschen Gesellschaft für Hämatologie und Onkologie
  • 2000 Wahl in das aus zehn Mitgliedern bestehende Scientific Advisory Board (Core Group) der International Working Group on CLL (IWCLL)
About the department keyboard_arrow_down

The Department I for Internal Medicine of the University Hospital Cologne deals with the treatment of patients with various internal diseases.

This includes in particular the following fields:

  • Oncology
  • Hematology
  • Clinical infectology
  • Clinical immunology
  • Hemostasis
  • Intensive care

The Department combines both clinical and research activities within these disciplines. Thus, this fact enables the provision of treatment according to the latest scientific findings and promotion of the international recognition.

The Department I of Internal Medicine of the University Hospital Cologne in Germany, under the direction of Univ.-Prof. Dr. Michael Hallek, is the Comprehensive Treatment Center for the patients with acute myeloid leukemia (AML), acute lymphatic leukemia (ALL) as well as myelodysplastic syndrome (MDS). However, the Department I of Internal Medicine offers the entire spectrum of services from high-quality diagnosis up to all the scientifically proven innovative therapies and up to the competent and thorough palliative treatment. Due to these achievements, the Department I of Internal Medicine of the University Hospital Cologne in Germany ranks among the largest centers of this kind.

Apart from the treatment of malignant blood diseases (chronic lymphocytic leukemia (CLL)), myelodysplastic syndrome (MDS) and acute leukemias (AML and ALL), the specialization field of the Department I of Internal Medicine of the University Hospital Cologne in Germany, under the direction of Univ.-Prof. Dr. Michael Hallek, includes the treatment of the following diseases:

  • Lymphatic tissue diseases, such as Hodgkin’s and non-Hodgkin’s lymphoma
  • Treatment within the clinical study, stem cell transplantation (SCT)
  • Oncological diseases
  • Infectology
  • HIV, immunology
  • Blood-clotting disorders
  • Internal intensive care 

Program includes:

  • Initial presentation in the clinic
  • clinical history taking
  • review of medical records
  • physical examination
  • laboratory tests:
    • complete blood count
    • general urine analysis
    • biochemical analysis of blood
    • TSH-basal, fT3, fT4
    • tumor markers
    • inflammation indicators
    • indicators blood coagulation
  • CT / MRI of the abdomen
  • abdominal ultrasound
  • 1 course of chemotherapy
  • nursing services
  • consultation of related specialists
  • treatment via head doctor and all leading experts
  • explanation of individual treatment plan

 

Total costs:
Type of program :
Duration of program:

{"only_for_children":"0","is_ambulant":"1","clinic_icon":"5813274a410c9.jpg","city":"Cologne","clinic_site":"http:\/\/www.uk-koeln.de\/","department_recommend":"1","program_full_story":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>clinical history taking<\/li>\n\t<li>review of medical records<\/li>\n\t<li>physical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>general urine analysis<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>tumor markers<\/li>\n\t\t<li>inflammation indicators<\/li>\n\t\t<li>indicators blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>CT \/ MRI of the abdomen<\/li>\n\t<li>abdominal ultrasound<\/li>\n\t<li>1 course of chemotherapy<\/li>\n\t<li>nursing services<\/li>\n\t<li>consultation of related specialists<\/li>\n\t<li>treatment via head doctor and all leading experts<\/li>\n\t<li>explanation of individual treatment plan<\/li>\n<\/ul>\n\n<p>&nbsp;<\/p>\n","country":"Germany","clinic_name":"University Hospital Cologne","department_id":"539","type":"treatment","duration":"5","direction":"Cancer","min_duration":0,"clinic_id":"261","title":"Chemotherapy with Cisplatin of teratoma (1 course)","price":{"val":"6765.00","type":"val"},"extra_service_clinic":[],"extra_service":[],"translation_hours":"0","translation_price":"40","translation_doc_price":"40","transfer_price":"3.00","transfer_price_vip":"5.00","roads":[{"id":"7","distance":"36","airport_title":"Cologne-Bonn"},{"id":"4","distance":"60","airport_title":"Duesseldorf"},{"id":"6","distance":"200","airport_title":"Frankfurt a.M."}]}

You may also book


Booking Health services:

remove_circle
add_circle
remove_circle
add_circle

Transfer

Total costs:




About hospital

Accommodation in hospital

Departments